Correction to Lancet Oncol 2015; 16: e227. Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging.
Lowy, D R
Correction to Lancet Oncol 2015; 16: e227. Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging. [electronic resource] - The Lancet. Oncology Jul 2015 - e313 p. digital
Publication Type: Published Erratum
1474-5488
10.1016/S1470-2045(15)00072-8 doi
Correction to Lancet Oncol 2015; 16: e227. Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging. [electronic resource] - The Lancet. Oncology Jul 2015 - e313 p. digital
Publication Type: Published Erratum
1474-5488
10.1016/S1470-2045(15)00072-8 doi